Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to ModerateCOVID-19:ARandomized Clinical Trial (vol 328, pg 1595, 2022)

被引：0
|
作者：
Naggie, S.
Boulware, D. R.
Lindsell, C. J.
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2023年 / 330卷 / 07期
关键词：
D O I：
10.1001/jama.2023.13799
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：666 / 666
页数：1
相关论文
共 10 条
  • [1] Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial (vol 328, pg 1595, 2022)
    Naggie, S.
    Boulware, D. R.
    Lindsell, C. J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (02): : 178 - 178
  • [2] Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19 A Randomized Clinical Trial
    Naggie, Susanna
    Boulware, David R.
    Lindsell, Christopher J.
    Stewart, Thomas G.
    Gentile, Nina
    Collins, Sean
    McCarthy, Matthew William
    Jayaweera, Dushyantha
    Castro, Mario
    Sulkowski, Mark
    McTigue, Kathleen
    Thicklin, Florence
    Felker, G. Michael
    Ginde, Adit A.
    Bramante, Carolyn T.
    Slandzicki, Alex J.
    Gabriel, Ahab
    Shah, Nirav S.
    Lenert, Leslie A.
    Dunsmore, Sarah E.
    Adam, Stacey J.
    DeLong, Allison
    Hanna, George
    Remaly, April
    Wilder, Rhonda
    Wilson, Sybil
    Shenkman, Elizabeth
    Hernandez, Adrian F.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (16): : 1595 - 1603
  • [3] Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial (vol 329, pg 296, 2023)
    Mccarthy, M. W.
    Naggie, S.
    Boulware, D. R.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (16): : 1589 - 1589
  • [4] Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19 A Randomized Clinical Trial
    McCarthy, Matthew W.
    Naggie, Susanna
    Boulware, David R.
    Lindsell, Christopher J.
    Stewart, Thomas G.
    Felker, G. Michael
    Jayaweera, Dushyantha
    Sulkowski, Mark
    Gentile, Nina
    Bramante, Carolyn
    Singh, Upinder
    Dolor, Rowena J.
    Ruiz-Unger, Juan
    Wilson, Sybil
    DeLong, Allison
    Remaly, April
    Wilder, Rhonda
    Collins, Sean
    Dunsmore, Sarah E.
    Adam, Stacey J.
    Thicklin, Florence
    Hanna, George
    Ginde, Adit A.
    Castro, Mario
    McTigue, Kathleen
    Shenkman, Elizabeth
    Hernandez, Adrian F.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (04): : 296 - 305
  • [5] Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial (vol 329, pg 888, 2023)
    Naggie, S.
    Boulware, D. R.
    Lindsell, C. J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (21): : 1867 - 1867
  • [6] Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19 A Randomized Clinical Trial
    Naggie, Susanna
    Boulware, David R.
    Lindsell, Christopher J.
    Stewart, Thomas G.
    Slandzicki, Alex J.
    Lim, Stephen C.
    Cohen, Jonathan
    Kavtaradze, David
    Amon, Arch P.
    Gabriel, Ahab
    Gentile, Nina
    Felker, G. Michael
    Jayaweera, Dushyantha
    McCarthy, Matthew W.
    Sulkowski, Mark
    Rothman, Russell L.
    Wilson, Sybil
    DeLong, Allison
    Remaly, April
    Wilder, Rhonda
    Collins, Sean
    Dunsmore, Sarah E.
    Adam, Stacey J.
    Thicklin, Florence
    Hanna, George J.
    Ginde, Adit A.
    Castro, Mario
    McTigue, Kathleen
    Shenkman, Elizabeth
    Hernandez, Adrian F.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (11): : 888 - 897
  • [7] Effect of Zuranolone vs Placebo in Postpartum Depression: ARandomized Clinical Trial (vol 78, pg 951, 2021)
    Deligiannidis, K. M.
    Meltzer-Brody, S.
    Gunduz-Bruce, H.
    JAMA PSYCHIATRY, 2023, 80 (02) : 191 - 191
  • [8] RETRACTION: Ivermectin role in COVID-19 treatment (IRICT): single-center, adaptive, randomized, double-blind, placebo-controlled, clinical trial (Retraction of Vol 20, Pg 1341, 2022)
    Elshafie, Ahmed Hanei
    Elsawah, Hozaifa Khalil
    Hammad, Mohamed
    Sweed, Eman Mohamed
    Seif, Ahmed Salah
    Ghaffar, Muhammad Mostafa Abdel
    Goda, Feisal Mahmoud
    Mosalam, Esraa M.
    Abdallah, Mahmoud S.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2024, 22 (06) : 495 - 495
  • [9] Effect of a Postoperative Multimodal Opioid-Sparing Protocol vs Standard Opioid Prescribing on Postoperative Opioid Consumption After Knee or Shoulder Arthroscopy: A Randomized Clinical Trial (vol 328, pg 1326, 2022)
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (22): : 2274 - 2274
  • [10] Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial (vol 327, pg 432, 2022)
    Kyaw, Akari
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (20): : 2024 - 2024
1